‘For-benefit’ pharma company launched

This week’s launch of Australia’s first ‘for-benefit’ pharmaceutical company is ushering in a new era of social enterprise that’s set to challenge the conventional for-profit pharma model, say stakeholders. For Benefit Medicines’ purpose is to distribute equally, 100% of profits generated from the sale of their two aromatase inhibitors, Anastrozole FBM and Letrozole FBM, to